• Mon, December 12, 2022

Edward White Maintained (SNDX) at Strong Buy with Increased Target to $33 on, Dec 12th, 2022

Edward White of HC Wainwright & Co., Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Strong Buy with Increased Target from $31 to $33 on, Dec 12th, 2022.

Edward, nor any peers, have made any analyst calls on SNDX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Like: 👍